APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Immune System Allergy Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Immune System Allergy Treatment Market Outlook and Growth Opportunities 2026

Report ID 174001980430 December 2025199 pages

Choose your research edition.

Industry ResearchImmune System Allergy Treatment Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune System Allergy Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Immune System Allergy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune System Allergy Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune System Allergy Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Immune System Allergy Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune System Allergy Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immune System Allergy Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immune System Allergy Treatment market include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Immune System Allergy Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune System Allergy Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune System Allergy Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immune System Allergy Treatment market.

Immune System Allergy Treatment Segment by Company

Sanofi

Johnson and Johnson Services, Inc.

Pfizer Inc.

GlaxoSmithKline plc

Stallergenes Greer

LETIPharma

Dermapharm Holding

Allergy Therapeutics

Allergan plc

ALK-Abelló A/S

Immune System Allergy Treatment Segment by Type

Allergy Injection

Sublingual Immunotherapy

Immune System Allergy Treatment Segment by Application

Hospital

Clinic

Others

Immune System Allergy Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Immune System Allergy Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Immune System Allergy Treatment key companies, revenue, market share, and recent developments.

3. To split the Immune System Allergy Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Immune System Allergy Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immune System Allergy Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Immune System Allergy Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune System Allergy Treatment industry.

Chapter 3: Detailed analysis of Immune System Allergy Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Immune System Allergy Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Immune System Allergy Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immune System Allergy Treatment Industry Trends Table 2. Immune System Allergy Treatment Industry Drivers Table 3. Immune System Allergy Treatment Industry Opportunities and Challenges Table 4. Immune System Allergy Treatment Industry Restraints Table 5. Global Immune System Allergy Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immune System Allergy Treatment Revenue Share by Company (2021-2026) Table 7. Global Immune System Allergy Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Immune System Allergy Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Immune System Allergy Treatment Company, Product Type & Application Table 10. Global Immune System Allergy Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Immune System Allergy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Allergy Injection Table 15. Significant Companies of Sublingual Immunotherapy Table 16. Global Immune System Allergy Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Immune System Allergy Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Immune System Allergy Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Immune System Allergy Treatment Sales Value Share by Type (2021-2026) Table 20. Global Immune System Allergy Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Immune System Allergy Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Immune System Allergy Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Immune System Allergy Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Immune System Allergy Treatment Sales Value Share by Application (2021-2026) Table 28. Global Immune System Allergy Treatment Sales Value Share by Application (2027-2032) Table 29. Global Immune System Allergy Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Immune System Allergy Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Immune System Allergy Treatment Sales Value Share by Region (2021-2026) Table 32. Global Immune System Allergy Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Immune System Allergy Treatment Sales Value Share by Region (2027-2032) Table 34. Global Immune System Allergy Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Immune System Allergy Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Immune System Allergy Treatment Sales Value Market Share by Country (2021-2026) Table 37. Global Immune System Allergy Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Immune System Allergy Treatment Sales Value Market Share by Country (2027-2032) Table 39. Sanofi Company Information Table 40. Sanofi Business Overview Table 41. Sanofi Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Sanofi Immune System Allergy Treatment Product Portfolio Table 43. Sanofi Recent Development Table 44. Johnson and Johnson Services, Inc. Company Information Table 45. Johnson and Johnson Services, Inc. Business Overview Table 46. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio Table 48. Johnson and Johnson Services, Inc. Recent Development Table 49. Pfizer Inc. Company Information Table 50. Pfizer Inc. Business Overview Table 51. Pfizer Inc. Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Pfizer Inc. Immune System Allergy Treatment Product Portfolio Table 53. Pfizer Inc. Recent Development Table 54. GlaxoSmithKline plc Company Information Table 55. GlaxoSmithKline plc Business Overview Table 56. GlaxoSmithKline plc Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio Table 58. GlaxoSmithKline plc Recent Development Table 59. Stallergenes Greer Company Information Table 60. Stallergenes Greer Business Overview Table 61. Stallergenes Greer Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Stallergenes Greer Immune System Allergy Treatment Product Portfolio Table 63. Stallergenes Greer Recent Development Table 64. LETIPharma Company Information Table 65. LETIPharma Business Overview Table 66. LETIPharma Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. LETIPharma Immune System Allergy Treatment Product Portfolio Table 68. LETIPharma Recent Development Table 69. Dermapharm Holding Company Information Table 70. Dermapharm Holding Business Overview Table 71. Dermapharm Holding Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Dermapharm Holding Immune System Allergy Treatment Product Portfolio Table 73. Dermapharm Holding Recent Development Table 74. Allergy Therapeutics Company Information Table 75. Allergy Therapeutics Business Overview Table 76. Allergy Therapeutics Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Allergy Therapeutics Immune System Allergy Treatment Product Portfolio Table 78. Allergy Therapeutics Recent Development Table 79. Allergan plc Company Information Table 80. Allergan plc Business Overview Table 81. Allergan plc Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Allergan plc Immune System Allergy Treatment Product Portfolio Table 83. Allergan plc Recent Development Table 84. ALK-Abelló A/S Company Information Table 85. ALK-Abelló A/S Business Overview Table 86. ALK-Abelló A/S Immune System Allergy Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio Table 88. ALK-Abelló A/S Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Immune System Allergy Treatment Product Image Figure 2. Global Immune System Allergy Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune System Allergy Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune System Allergy Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Allergy Injection Image Figure 8. Sublingual Immunotherapy Image Figure 9. Global Immune System Allergy Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Immune System Allergy Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Immune System Allergy Treatment Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Immune System Allergy Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Immune System Allergy Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Immune System Allergy Treatment Sales Value Share by Application (2021-2032) Figure 18. Global Immune System Allergy Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Immune System Allergy Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Immune System Allergy Treatment Sales Value (2021-2032) & (US$ Million) Figure 21. North America Immune System Allergy Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Immune System Allergy Treatment Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Immune System Allergy Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Immune System Allergy Treatment Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Immune System Allergy Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Immune System Allergy Treatment Sales Value (2021-2032) & (US$ Million) Figure 27. South America Immune System Allergy Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Immune System Allergy Treatment Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Immune System Allergy Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Immune System Allergy Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Allergy Injection
  • Sublingual Immunotherapy
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Stallergenes Greer
  • LETIPharma
  • Dermapharm Holding
  • Allergy Therapeutics
  • Allergan plc
  • ALK-Abelló A/S

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune System Allergy Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune System Allergy Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Immune System Allergy Treatment Market Dynamics
  1. 2.1 Immune System Allergy Treatment Industry Trends
  2. 2.2 Immune System Allergy Treatment Industry Drivers
  3. 2.3 Immune System Allergy Treatment Industry Opportunities and Challenges
  4. 2.4 Immune System Allergy Treatment Industry Restraints
3 Immune System Allergy Treatment Market by Company
  1. 3.1 Global Immune System Allergy Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Immune System Allergy Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Immune System Allergy Treatment Company Ranking (2024-2026)
  4. 3.4 Global Immune System Allergy Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Immune System Allergy Treatment Company Product Type and Application
  6. 3.6 Global Immune System Allergy Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Immune System Allergy Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Immune System Allergy Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Immune System Allergy Treatment Market by Type
  1. 4.1 Immune System Allergy Treatment Type Introduction
  2. 4.1.1 Allergy Injection
  3. 4.1.2 Sublingual Immunotherapy
  4. 4.2 Global Immune System Allergy Treatment Sales Value by Type
  5. 4.2.1 Global Immune System Allergy Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Immune System Allergy Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Immune System Allergy Treatment Sales Value Share by Type (2021-2032)
5 Immune System Allergy Treatment Market by Application
  1. 5.1 Immune System Allergy Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Immune System Allergy Treatment Sales Value by Application
  6. 5.2.1 Global Immune System Allergy Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immune System Allergy Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Immune System Allergy Treatment Sales Value Share by Application (2021-2032)
6 Immune System Allergy Treatment Regional Value Analysis
  1. 6.1 Global Immune System Allergy Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune System Allergy Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Immune System Allergy Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Immune System Allergy Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune System Allergy Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Immune System Allergy Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Immune System Allergy Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Immune System Allergy Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Immune System Allergy Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Immune System Allergy Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Immune System Allergy Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Immune System Allergy Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Immune System Allergy Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Immune System Allergy Treatment Sales Value Share by Country, 2025 VS 2032
7 Immune System Allergy Treatment Country-level Value Analysis
  1. 7.1 Global Immune System Allergy Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immune System Allergy Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Immune System Allergy Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Immune System Allergy Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Immune System Allergy Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Immune System Allergy Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Immune System Allergy Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Immune System Allergy Treatment Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson and Johnson Services, Inc.
  8. 8.2.1 Johnson and Johnson Services, Inc. Company Information
  9. 8.2.2 Johnson and Johnson Services, Inc. Business Overview
  10. 8.2.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio
  12. 8.2.5 Johnson and Johnson Services, Inc. Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Immune System Allergy Treatment Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 GlaxoSmithKline plc
  20. 8.4.1 GlaxoSmithKline plc Company Information
  21. 8.4.2 GlaxoSmithKline plc Business Overview
  22. 8.4.3 GlaxoSmithKline plc Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc Recent Developments
  25. 8.5 Stallergenes Greer
  26. 8.5.1 Stallergenes Greer Company Information
  27. 8.5.2 Stallergenes Greer Business Overview
  28. 8.5.3 Stallergenes Greer Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stallergenes Greer Immune System Allergy Treatment Product Portfolio
  30. 8.5.5 Stallergenes Greer Recent Developments
  31. 8.6 LETIPharma
  32. 8.6.1 LETIPharma Company Information
  33. 8.6.2 LETIPharma Business Overview
  34. 8.6.3 LETIPharma Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LETIPharma Immune System Allergy Treatment Product Portfolio
  36. 8.6.5 LETIPharma Recent Developments
  37. 8.7 Dermapharm Holding
  38. 8.7.1 Dermapharm Holding Company Information
  39. 8.7.2 Dermapharm Holding Business Overview
  40. 8.7.3 Dermapharm Holding Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dermapharm Holding Immune System Allergy Treatment Product Portfolio
  42. 8.7.5 Dermapharm Holding Recent Developments
  43. 8.8 Allergy Therapeutics
  44. 8.8.1 Allergy Therapeutics Company Information
  45. 8.8.2 Allergy Therapeutics Business Overview
  46. 8.8.3 Allergy Therapeutics Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Allergy Therapeutics Immune System Allergy Treatment Product Portfolio
  48. 8.8.5 Allergy Therapeutics Recent Developments
  49. 8.9 Allergan plc
  50. 8.9.1 Allergan plc Company Information
  51. 8.9.2 Allergan plc Business Overview
  52. 8.9.3 Allergan plc Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allergan plc Immune System Allergy Treatment Product Portfolio
  54. 8.9.5 Allergan plc Recent Developments
  55. 8.10 ALK-Abelló A/S
  56. 8.10.1 ALK-Abelló A/S Company Information
  57. 8.10.2 ALK-Abelló A/S Business Overview
  58. 8.10.3 ALK-Abelló A/S Immune System Allergy Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio
  60. 8.10.5 ALK-Abelló A/S Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst